We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Sapio Sciences Logo

Sapio Sciences

Sapio Sciences is a technology company that develops software to support drug research and discovery processes. Founded by Kevin Cramer, Sapio Sciences has developed software products for laboratory operations, particularly in biotechnology and chemistry.

Latest Content

Cover of Sapio Sciences whitepaper comparing lab products vs. platforms with images of frustrated and happy scientists
Whitepaper

Understanding the DNA of a Unified Laboratory Informatics Platform

This Sapio Sciences whitepaper clarifies the difference between a platform and a product, advocating for unified, scalable informatics solutions across lab operations.
Whitepaper cover by Sapio Sciences titled 'From Data Silos to Data Synergy' with images of scientists and data flow graphics
Whitepaper

From Data Silos to Data Synergy

This Sapio Sciences whitepaper presents a framework for integrating scientific data using Sapio’s Scientific Data Cloud to enable enterprise-wide access and AI-driven insights.
Whitepaper cover by Sapio Sciences on overcoming bottlenecks in high-throughput clinical labs, with a white flag illustration
Whitepaper

Overcoming Operational Bottlenecks in High-Throughput Clinical Labs

This Sapio Sciences whitepaper outlines strategies to resolve turnaround delays, traceability gaps, data fragmentation, and compliance issues in clinical diagnostic labs.
Science-Aware AI poster by Sapio Sciences showing lab scenes and AI benefits in drug discovery and development
Whitepaper

What is Science-Aware AI?

This Sapio Sciences whitepaper explores how science-aware AI enhances drug discovery, clinical development, and pharma manufacturing through domain-specific intelligence and automation.
Cover of a whitepaper titled 'The High Price of Holding on to Outdated LIMS Products' by Sapio Sciences
Whitepaper

The High Price of Holding on to Outdated LIMS Products

This Sapio Sciences white paper examines the risks of using outdated LIMS products and makes the case for transitioning to a unified, modern laboratory platform.
Lab metrics dashboard displaying charts for queue time, TAT, workflow counts, and user performance, with navigation sidebar.
Product
Advertisement

Sapio Platform

The Sapio Platform is the first AI-native lab informatics solution to unify ELN, LIMS, and SDMS into a single platform, supporting R&D, clinical, and manufacturing labs by streamlining scientific workflows and standardizing data.
Dashboard interface showing lab metrics with bar charts, a pie chart, a funnel chart, and navigation panel on the left
Product
Advertisement

Sapio LIMS (Laboratory Information Management System)

Sapio LIMS is a no-code, AI-native Laboratory Information Management System enabling scientific users to configure workflows, track samples/materials, and ensure compliance in research, clinical, and manufacturing labs
Plasmid editor interface showing original and modified vectors with design inputs and a DNA sequence at the bottom
Product
Advertisement

Sapio ELN (Electronic Lab Notebook)

A no-code, science-aware ELN for modern labs. Sapio ELN supports structured and free-form experiments, AI-native assistance, and deep integration with LIMS and SDMS to streamline workflows and enable faster, more reproducible research
Software dashboard showing navigation menu and project details with tabs for details, configurations, and sync logs
Product
Advertisement

Sapio SDMS (Scientific Data Management System)

A no-code, science-aware SDMS for modern labs. Sapio Scientific Data Cloud unifies and contextualizes data across instruments and systems, delivering AI-ready insights, seamless integration, and frictionless scientific analysis at scale
Cover of Sapio Sciences' report featuring a modern design with scientific imagery and a preview of the introduction page
Whitepaper

Accelerate Digital Transformation in Biopharma R&D

This whitepaper explores how unified informatics platforms are revolutionizing biopharmaceutical R&D.
Advertisement